Concepedia

Holly Symolon

HS

4

Publications

312

Citations

4

H-Index

2004

Active since

Affiliations

Georgia Institute of Technology(Current)

Emory University

Holly Symolon is an author at Georgia Institute of Technology specializing in pharmacology, medicine, and cell biology.

Top concepts

MedicineCell BiologyPharmacologyDrug DiscoveryCancer ResearchCancer Cell BiologyOncologyCell DeathBiochemistryTumor Biology

Publications per year

2004–2011

4

Publications

4

Dietary Soy Sphingolipids Suppress Tumorigenesis and Gene Expression in 1,2-Dimethylhydrazine-Treated CF1 Mice and Apc/+ Mice

Holly Symolon, Eva M. Schmelz, Dirck L. Dillehay et al. · Journal of Nutrition · 2004 · 126 citations · Full text

Chemoprevention Strategy, Medicine, Lipid Peroxidation +7

<i>N</i>-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing

Hongtao Wang, Barry J. Maurer, Yu Liu et al. · Molecular Cancer Therapeutics · 2008 · 102 citations · Full text

Medicinal Chemistry, Drug Targeting, Chemoprevention Strategy +14

Enigmol: A Novel Sphingolipid Analogue with Anticancer Activity against Cancer Cell Lines and <i>In vivo</i> Models for Intestinal and Prostate Cancer

Holly Symolon, Anatoliy Bushnev, Qiong Peng et al. · Molecular Cancer Therapeutics · 2011 · 61 citations · Full text

Chemoprevention Strategy, Cancer Biology, Tumor Biology +20

Safingol Toxicology After Oral Administration to TRAMP Mice: Demonstration of Safingol Uptake and Metabolism by N-Acylation and N-Methylation

Pablo Morales, Dirck L. Dillehay, Steven J. Moody et al. · Drug and Chemical Toxicology · 2007 · 23 citations

Rows per page

1–4 of 4